InvestorsHub Logo
Followers 276
Posts 32461
Boards Moderated 0
Alias Born 11/14/2013

Re: None

Thursday, 10/30/2014 12:39:29 PM

Thursday, October 30, 2014 12:39:29 PM

Post# of 689593
Extensive scientific evidence has shown that there is substantial variation in tumor profiles and characteristics among patients with the “same” cancer. The degree of variation is particularly enormous in some of the most aggressive cancers, such as GBM brain cancer and pancreatic cancer. DCVax is designed to target the full set of biomarkers on a patient’s cancer. Such a treatment approach makes it more difficult for tumors to develop escape variants. Source: NWBIO Website

Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News